Form 4: Elanco Animal Health Executive Receives Stock Options

David S. Kinard, an executive at Elanco Animal Health Inc., was granted stock options with a vesting schedule spanning three years.

Summary

• David S. Kinard, Executive Vice President of Human Resources, Corporate Affairs and Administration at Elanco Animal Health Inc., received a grant of employee stock options.
• The options have an exercise price of $24.09 per share.
• A total of 25,620 stock options were granted.
• These options are set to vest in three equal tranches: one-third on March 1, 2027, one-third on March 1, 2028, and the remaining one-third on March 1, 2029.
• The transaction date for this grant was July 1, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard executive compensation practices rather than significant company performance news.

Positives

• Grant of stock options to a key executive, indicating a commitment to retaining and incentivizing leadership.
• The exercise price of $24.09 suggests a potential for future stock appreciation from the grant date.
• The vesting schedule over three years aligns executive interests with long-term company performance.

Risks

• The value of the stock options is contingent on the future performance of Elanco Animal Health's stock price.
• If the stock price does not exceed the exercise price of $24.09, the options may not be exercised profitably.

Future Outlook

The grant of stock options with a three-year vesting schedule suggests management's confidence in the company's future performance and stock appreciation.

Industry Context

StockSavvy.ai notes that the granting of stock options to executives is a common practice in the animal health industry to align leadership incentives with shareholder value and long-term growth.

Stakeholder Impact

• Shareholders: The grant of options aligns executive interests with long-term shareholder value, potentially leading to increased focus on stock price appreciation.
• Employees: May be seen as a positive sign of executive commitment and potential company growth, though direct impact is limited.
• Management: Reinforces the incentive structure for executive leadership.

Next Steps

• The executive will receive vested stock options according to the specified schedule.
• The executive may choose to exercise the vested options if the stock price is favorable.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Stock Options, Executive Compensation, Insider Trading, Securities, Grant, Vesting